Cellbyte is building an AI-native platform to help pharma companies launch new drugs worldwide. The company empowers pharma commercial teams to cut through complexity, analyze previously fragmented data in seconds, and automate high-stakes workflows. It builds AI agents for pharmaceutical drug launches and automates repetitive workflows on a robust data foundation, helping bring life-changing treatments to patients faster. Backed by Y-Combinator, Cellbyte positions itself as an AI-native platform for pharma drug launches.
Felix Steinbrenner
Co-founder & CEO of Cellbyte. Building AI agents to accelerate the launch and commercialization of pharmaceutical drugs.